Accord Logo

Intended for UK patients and members of the public

Dipyridamole Tablets

Active Ingredients

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Dipyridamole Tablets BP 100mg

PL Number:
0142/0309
MA Holder:
Accord-UK Ltd
Product Classification:
POM
Product Status:
Active

Product Documentation

  • Variation Description: SmPC sections 2, 4.4 and 4.8 have been updated to amend side-effect frequencies in line with the recommendation from the MHRA after approval of variation ref PL 00142/0308 - 0060 and to include the Excipients of known effect section. Consequentially, the cartons and PIL have also been updated to correct the excipient declarations in line with current QRD template.

     SmPC sections updated – 2, 4.4, 4.8 and 10.

  • Variation Description: SmPC sections 2, 4.4 and 4.8 have been updated to amend side-effect frequencies in line with the recommendation from the MHRA after approval of variation ref PL 00142/0308 - 0060 and to include the Excipients of known effect section. Consequentially, the cartons and PIL have also been updated to correct the excipient declarations in line with current QRD template.

    PIL sections updated – 2, 4 and 6.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Dipyridamole Tablets BP 25mg

PL Number:
0142/0308
MA Holder:
Accord-UK Ltd
Product Classification:
POM
Product Status:
Active

Product Documentation

  • Variation Description: SmPC sections 2, 4.4 and 4.8 have been updated to amend side-effect frequencies in line with the recommendation from the MHRA after approval of variation ref PL 00142/0308 - 0060 and to include the Excipients of known effect section. Consequentially, the cartons and PIL have also been updated to correct the excipient declarations in line with current QRD template.

     SmPC sections updated – 2, 4.4, 4.8 and 10.

  • Variation Description: SmPC sections 2, 4.4 and 4.8 have been updated to amend side-effect frequencies in line with the recommendation from the MHRA after approval of variation ref PL 00142/0308 - 0060 and to include the Excipients of known effect section. Consequentially, the cartons and PIL have also been updated to correct the excipient declarations in line with current QRD template.

    PIL sections updated – 2, 4 and 6.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

General FAQs

For any further assistance, please get in touch.

View product information as a: